A new study has been published in the journal Antioxidants and Redox Signaling by Dr. Bobby Thomas who is a neuroscientist with the Medical College of Georgia at Georgia Health Sciences University. His study shows that NRF2 activation in an animal model boosts the cells production of its own antioxidant enzymes and manages inflammation at the same time. This helps the cells recover from the damaging effects of high oxidative stress associated with Parkinson’s disease.

More specifically, Thomas and his fellow researchers proved that they were able to block the death of dopamine-producing brain cells that occurs in Parkinson’s by activating Nrf2, a natural antioxidant and inflammation fighter.

Parkinson’s Disease Symptoms Include:

  • Tremors
  • Slowed movement (bradykinesia).
  • Rigid muscles/Muscle stiffness
  • Loss of automatic movements including blinking, smiling or swinging your arms when you walk.
  •  Speech changes

This is not the first study to have been completed on NRF-2 and Parkinson’s. Pubmed has the following additional studies.

Information provided on this site is for educational purposes only. Do your own research, and consult with a medical professional about your findings.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

JOIN OUR COMMUNITY.

Reach Us

Our mission is to provide an impartial review of the emerging research regarding Nrf2 activation.

We welcome the involvement of those who have published peer review studies in this field. 

Should you wish to contact us, please leave a message using the adjacent form. 

 

    Researching Nrf2? Leave us a message to collaborate

    Pin It on Pinterest

    Share This